Pages that link to "Q38550389"

The following pages link to In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants (Q38550389):

Displaying 47 items.

• Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis (Q28086953) (← links)
• Externally controlled triggered-release of drug from PLGA micro and nanoparticles (Q28542537) (← links)
• Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning (Q30370009) (← links)
• Novel factor-loaded polyphosphazene matrices: potential for driving angiogenesis (Q30373047) (← links)
• Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus (Q33721979) (← links)
• Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds (Q33742858) (← links)
• Cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis (Q33834548) (← links)
• Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. (Q33864915) (← links)
• The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices (Q34072262) (← links)
• β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics andin vitrorelease (Q34147976) (← links)
• In vitro degradation and release characteristics of spin coated thin films of PLGA with a "breath figure" morphology (Q34626871) (← links)
• Rapid manufacturing techniques for the tissue engineering of human heart valves (Q35213334) (← links)
• In vitro and in vivo evaluations of biodegradable implants for hormone replacement therapy: effect of system design and PK-PD relationship (Q37360879) (← links)
• Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery (Q37464405) (← links)
• Nanoparticles containing insoluble drug for cancer therapy (Q37693046) (← links)
• Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery (Q37709424) (← links)
• Bone substitutes in orthopaedic surgery: from basic science to clinical practice (Q38215317) (← links)
• Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles. (Q38826606) (← links)
• Proanthocyanidins-Loaded Nanoparticles Enhance Dentin Degradation Resistance. (Q38969431) (← links)
• Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel (Q38983629) (← links)
• Novel poly-DL-lactide-polycaprolactone copolymer based flexible drug delivery system for sustained release of ciprofloxacin (Q39614940) (← links)
• Novel Modeling Approach to Generate a Polymeric Nanofiber Scaffold for Salivary Gland Cells (Q39673592) (← links)
• A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo (Q40629823) (← links)
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (Q42153590) (← links)
• Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats (Q42181711) (← links)
• Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles. (Q42549724) (← links)
• Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery (Q43130340) (← links)
• Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation (Q43702603) (← links)
• Synthetic biodegradable polymers as orthopedic devices (Q43720685) (← links)
• Self-curing acrylic formulations containing PMMA/PCL composites: properties and antibiotic release behavior (Q43986888) (← links)
• Characterization of crosslinked high amylose starch matrix implants. 1. In vitro release of ciprofloxacin (Q44054848) (← links)
• Characterization of crosslinked high amylose starch matrix implants. 2. In vivo release of ciprofloxacin (Q44054853) (← links)
• Studies on biodegradation and release of gentamicin sulphate from interpenetrating network hydrogels based on poly(acrylic acid) and gelatin: in vitro and in vivo (Q44633498) (← links)
• A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery. (Q46358349) (← links)
• Porous biodegradable microparticles for delivery of pentamidine (Q46379068) (← links)
• Encapsulation of Nicardipine Hydrochloride and Release from Biodegradable Poly(D,L-lactic-co-glycolic acid) Microparticles by Double Emulsion Process: Effect of Emulsion Stability and Different Parameters on Drug Entrapment. (Q47128940) (← links)
• Effect of molecular weight and polydispersity on kinetics of dissolution and release from ph/temperature-sensitive polymers (Q47251854) (← links)
• 3D printed TCP-based scaffold incorporating VEGF-loaded PLGA microspheres for craniofacial tissue engineering (Q47703351) (← links)
• Biodegradable Polymers in Bone Tissue Engineering. (Q49224618) (← links)
• Promoting vascular healing using nanofibrous ticagrelor-eluting stents (Q57483012) (← links)
• Preparation and characterisation of bioactive hydroxyapatite–silica composite nanopowders via sol–gel method for medical applications (Q58271623) (← links)
• Preparation and Evaluation of Pralidoxime-Loaded PLGA Nanoparticles as Potential Carriers of the Drug across the Blood Brain Barrier (Q59113960) (← links)
• Self-assembled micelles prepared from poly(ɛ-caprolactone)-poly(ethylene glycol) and poly(ɛ-caprolactone/glycolide)-poly(ethylene glycol) block copolymers for sustained drug delivery (Q59307344) (← links)
• Enhanced Endothelialization of a New Stent Polymer Through Surface Enhancement and Incorporation of Growth Factor-Delivering Microparticles (Q61634107) (← links)
• Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes (Q77969450) (← links)
• A novel risperidone-loaded SAIB–PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo (Q82962690) (← links)
• Control of cilostazol release kinetics and direction from a stent using a reservoir‐based design (Q83354147) (← links)